"Isolate Id","Study","Species","Organism Group","Country","State","Gender","Age Group","Speciality","Source","In / Out Patient","Year","Phenotype","MIC","breakpoint","Drug"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"2","Susceptible","Amikacin"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"8","Susceptible","Amoxycillin clavulanate"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,">32","Resistant","Ampicillin"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"0.25","Susceptible","Cefepime"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"0.12","Susceptible","Ceftazidime"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"0.5","Susceptible","Ceftriaxone"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"0.25","Susceptible","Imipenem"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"<=0.03","Susceptible","Levofloxacin"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"0.03","Susceptible","Meropenem"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"<=0.25","Susceptible","Piperacillin tazobactam"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"0.25","Susceptible","Tigecycline"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"<=0.015","Susceptible","Aztreonam"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"32","Resistant","Ceftaroline"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"0.03","Susceptible","Ceftazidime avibactam"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"0.06","Susceptible","Doripenem"
"1602956","Inform","Proteus hauseri","Enterobacteriaceae","Colombia",NA,"Male","0 to 2 Years","Pediatric General","INT: Abscess","Inpatient","2017",NA,"1","Susceptible","Ceftolozane tazobactam"
